CSPC Pharmaceutical Group Ltd

Common Name
CSPC Pharmaceutical Group
Country
China (Mainland)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
21,400
Ticker
1093
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
CSPC Pharmaceutical Group Ltd. is a prominent player in the pharmaceutical industry, focusing on the research, development, manufacture, and commercialization of a wide array of pharmaceutical product...

CSPC Pharmaceutical Group's Climate Target Data Preview

As of 2023, CSPC Pharmaceutical Group has disclosed 4 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 4 intensity-based targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into CSPC Pharmaceutical Group ’s climate strategy, ambition level, and alignment with global decarbonization goals.

Target TypeScope of TargetUnitTargetTarget Year
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue
Copy restricted. Please purchase to unlock this data.
2025
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue
Copy restricted. Please purchase to unlock this data.
2026
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue
Copy restricted. Please purchase to unlock this data.
2028
Intensity-based Target
Scope 1 - Total, Scope 2 - Total
Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue
Copy restricted. Please purchase to unlock this data.
2030

This table provides a simplified preview of selected climate targets data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into CSPC Pharmaceutical Group's Greenhouse Gas Emissions Pathways

As of 2023, CSPC Pharmaceutical Group has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.

Does CSPC Pharmaceutical Group have a target to reduce the emissions from its operations?

As of 2023, CSPC Pharmaceutical Group has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.

CSPC Pharmaceutical Group's most ambitious operational target is to reduce these emissions by 50% by 2025, compared to a baseline of 0 Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue in 2017.

CSPC Pharmaceutical Group has already surpassed its operational emissions reduction target, with 2023 levels falling below the 2025 value, achieving its climate goal ahead of schedule.

CSPC Pharmaceutical Group's Operational (Scope 1+2) Emissions Pathway

20172023202500000BaselineCurrent (-52%)
Want Full Access to CSPC Pharmaceutical Group's Climate Targets Dataset?
Sign Up